Supriya Lifescience Files Annual Report 2025-26

Supriya Lifescience Ltd has submitted its Annual Report for the financial year 2025-26, which includes the Business Responsibility and Sustainability Report. The report details the company's performance, strategic initiatives, and ESG commitments. The 18th Annual General Meeting (AGM) is scheduled for September 24, 2026, to be held via Video Conferencing. The report highlights the company's highest-ever revenue and EBITDA, driven by strong demand, favorable product mix, backward integration, and disciplined execution. Supriya Lifescience is focusing on API franchise enhancement, new product development, R&D capabilities, and expanding into formulations and specialized dosage forms. The Annual Report is available on the company's website.